[Federal Register Volume 79, Number 191 (Thursday, October 2, 2014)]
[Notices]
[Pages 59521-59522]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2014-23509]


=======================================================================
-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION

[NRC-2014-0212]


Oversight of Counterfeit, Fraudulent, and Suspect Items in the 
Nuclear Industry

AGENCY: Nuclear Regulatory Commission.

ACTION: Draft regulatory issue summary; public meeting and request for 
comment.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) is seeking public 
comment on draft regulatory issue summary (RIS) 2014-XX. This draft 
RIS, if finalized, is intended to heighten awareness of existing NRC's 
regulations and reiterate how they apply to the nuclear industry 
stakeholders' oversight of counterfeit, fraudulent, and suspect items 
(CFSI) to all NRC's licensees and certificate holders, Agreement State 
radiation control program directors, state liason officers, contractors 
and vendors.

DATES: Submit comments by November 3, 2014. Comments received after 
this date will be considered if it is practical to do so, but the NRC 
is able to assure consideration only for comments received on or before 
this date.

ADDRESSES: You may submit comment by any of the following methods 
(unless this document describes a different method for submitting 
comments on a specific subject):
     Federal Rulemaking Web site: Go to http://www.regulations.gov and search for Docket ID NRC-2014-0212. Address 
questions about NRC dockets to Carol Gallagher; telephone: 301-287-
3422; email: [email protected]. For technical questions, contact 
the individual(s) listed in the FOR FURTHER INFORMATION CONTACT section 
of this document.
     Mail comments to: Cindy Bladey, Office of Administration, 
Mail Stop: 3WFN, 06-44M, U.S. Nuclear Regulatory Commission, 
Washington, DC 20555-0001.
    For additional direction on accessing information and submitting 
comments, see ``Obtaining Information and Submitting Comments'' in the

[[Page 59522]]

SUPPLEMENTARY INFORMATION section of this document.

FOR FURTHER INFORMATION CONTACT: Tanya Mensah, Office of Nuclear 
Reactor Regulation, telephone: 301-415-3610, email: 
[email protected]; or James Gaslevic, Office of New Reactors, 
telephone: 301-415-2776, email: [email protected], both are staff 
of the U.S. Nuclear Regulatory Commission, Washington, DC 20555-0001.

SUPPLEMENTARY INFORMATION: 

I. Obtaining Information and Submitting Comments

A. Obtaining Information

    Please refer to Docket ID NRC-2014-0212 when contacting the NRC 
about the availability of information for this action. You may obtain 
publicly-available information related to this action by any of the 
following methods:
     Federal Rulemaking Web site: Go to http://www.regulations.gov and search for Docket ID NRC-2014-0212.
     NRC's Agencywide Documents Access and Management System 
(ADAMS): You may obtain publicly-available documents online in the 
ADAMS Public Documents collection at http://www.nrc.gov/reading-rm/adams.html. To begin the search, select ``ADAMS Public Documents'' and 
then select ``Begin Web-based ADAMS Search.'' For problems with ADAMS, 
please contact the NRC's Public Document Room (PDR) reference staff at 
1-800-397-4209, 301-415-4737, or by email to [email protected]. The 
ADAMS accession number for each document referenced (if it is available 
in ADAMS) is provided the first time that it is mentioned in the 
SUPPLEMENTARY INFORMATION section.
     NRC's PDR: You may examine and purchase copies of public 
documents at the NRC's PDR, Room O1-F21, One White Flint North, 11555 
Rockville Pike, Rockville, Maryland 20852.

B. Submitting Comments

    Please include Docket ID NRC-2014-0212 in the subject line of your 
comment submission, in order to ensure that the NRC is able to make 
your comment submission available to the public in this docket.
    The NRC cautions you not to include identifying or contact 
information that you do not want to be publicly disclosed in your 
comment submission. The NRC posts all comment submissions at http://www.regulations.gov as well as entering the comment submissions into 
ADAMS. The NRC does not routinely edit comment submissions to remove 
identifying or contact information.
    If you are requesting or aggregating comments from other persons 
for submission to the NRC, then you should inform those persons not to 
include identifying or contact information that they do not want to be 
publicly disclosed in their comment submission. Your request should 
state that the NRC does not routinely edit comment submissions to 
remove such information before making the comment submissions available 
to the public or entering the comment submissions into ADAMS.

II. Background

    The NRC issues RISs to communicate with stakeholders on a broad 
range of regulatory matters. This may include communicating staff 
technical positions on matters that have not been communicated to or 
are not broadly understood by the nuclear industry.
    The NRC staff has developed draft RIS 2014-XX, ``Oversight of 
Counterfeit, Fraudulent, and Suspect Items in the Nuclear Industry,'' 
to heighten awareness of the existing NRC regulations and how they 
apply to the nuclear stakeholders' oversight of CFSI. The NRC 
assessment is that the regulatory provisions identified and discussed 
in the draft RIS: (i) Provide sufficient authority for the NRC to take 
regulatory action addressing CFSI issues within the scope of the NRC's 
regulatory authority and jurisdiction; and (ii) are sufficiently clear 
and comprehensive to alert regulated entities with respect to their 
responsibilities and obligations with respect to CFSI as established 
under those NRC regulatory provisions. The NRC requests comments on the 
NRC's assessment. If commenters disagree with the NRC's assessment, 
then the NRC requests that commenters identify the specific matter or 
area in which the NRC's regulatory infrastructure is deficient or 
incomplete, and how the NRC could address or rectify the deficiency or 
incompleteness. Comments identifying needed changes would be most 
helpful if they describe the entities involved, the specific matter, 
situation or deficiency in the NRC's infrastructure, and a description 
of the proposed activity or regulatory prohibition needed to 
successfully address the matter, situation or deficiency.
    The RIS, if issued in final form, may be used by all NRC's 
licensees and certificate holders, Agreement State radiation control 
program directors, state liason officers, contractors and vendors. The 
draft RIS explains that these entities may review this information and 
consider actions, as appropriate, to prevent CFSI from entering their 
supply chains, prevent possible installation or use of CFSI at their 
facilities, and raise awareness of the potential for CFSI to be used in 
the manufacture of items, including sealed sources and devices. The 
draft RIS is available electronically in ADAMS under Accession No. 
ML14192B407.

Public Meeting

    The NRC plans to hold a public meeting to discuss the draft RIS and 
the issues associated with CFSI. The NRC will consider oral comments 
made in developing the final RIS, but the NRC will not prepare formal 
written comment responses to oral comments made at the public meeting. 
You may submit written comments either electronically or in writing, as 
described in the ADDRESSES section of this document. Additional details 
regarding the meeting will be posted at least 10 days prior to the 
public meeting on the NRC's Public Meeting Schedule Web site at http://www.nrc.gov/public-involve/public-meetings/index.cfm.

    Dated at Rockville, Maryland, this 25th day of September 2014.

    For the Nuclear Regulatory Commission.
Sheldon D. Stuchell,
Chief, Generic Communications Branch, Division of Policy and 
Rulemaking, Office of Nuclear Reactor Regulation.
[FR Doc. 2014-23509 Filed 10-1-14; 8:45 am]
BILLING CODE 7590-01-P